China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021
The global Drugs for Treatment of Prostate Cancer market was valued at USD 30.41 Billion in 2015, and is projected to reach USD 35.26 Billion by 2021, at a CAGR of 59.49% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs
This report studies Drugs for Treatment of Prostate Cancer in China, Russia, Brazil and Japan market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer forecast to 2021, from 2015.
On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.
On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.
On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.
On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.
With 220ges, 231 charts and eight chapters, to display the market present situation and future, clearly and deeply.
This report studies Drugs for Treatment of Prostate Cancer in China, Russia, Brazil and Japan market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer forecast to 2021, from 2015.
On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.
On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.
On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.
On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.
With 220ges, 231 charts and eight chapters, to display the market present situation and future, clearly and deeply.
China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021
1 DRUGS FOR TREATMENT OF PROSTATE CANCER OVERVIEW AND EACH TYPE
1.1 Product Overview of Prostate Cancer
1.1.1 Definition and Product Scope of Drugs for Prostate Cancer
1.1.2 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.3 Russia Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.4 Brazil Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.5 Japan Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List and of Each Type 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Triptorelin and Specification
1.2.5 Leuprorelin and Specification
1.2.6 Flutamide Tablets and Specification
1.2.7 Goserelin and Specification
1.2.8 Bicalutamide Tablets and Specification
1.2.9 Bicalutamide Capsules and Specification
1.2.10 Estramustine Phosphate Capsules and Specification
1.2.11 Mitoxantrone and Specification
1.2.12 Zytiga and Specification
1.2.13 Xtandi and Specification
1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016
1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers
1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers
1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers
1.3.4 Price List (Interviewed) of Goserelin by Manufacturers
1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers
1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers
1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers
1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers
1.3.9 Price List (Interviewed) of Zytiga by Manufacturers
1.3.10 Price List (Interviewed) of Xtandi by Manufacturers
2 COMPETITION ANALYSIS BY MANUFACTURERS IN GLOBAL AND CHINA
2.1 Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.3 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.4 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.5 Russia Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.6 Russia Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.7 Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.8 Brazil Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.9 Brazil Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.10 Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.11 Japan Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.12 Japan Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.13 Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
3 SALES AND REVENUE SEGMENTS OF EACH TYPE 2010 TO 2015
3.1 China Sales and Revenue Segments of Each Type 2010 to 2015
3.1.1 China Sales and Market Share of Each Type 2010 to 2015
3.1.2 China Sales Growth Rate of Each Type 2015 to 2016
3.1.3 China Revenue and Market Share of Each Type 2015 to 2016
3.1.4 China Revenue and Market Share of Each Type 2015 to 2016
3.2 Russia Sales and Revenue Segments of Each Type 2015 to 2016
3.2.1 Russia Sales and Market Share of Each Type 2015 to 2016
3.2.2 Russia Sales Growth Rate of Each Type 2015 to 2016
3.2.3 Russia Revenue and Market Share of Each Type 2015 to 2016
3.2.4 Russia Revenue and Market Share of Each Type 2015 to 2016
3.3 Brazil Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Brazil Sales and Market Share of Each Type 2015 to 2016
3.3.2 Brazil Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.4 Japan Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Japan Sales and Market Share of Each Type 2015 to 2016
3.3.2 Japan Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Japan Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Japan Revenue and Market Share of Each Type 2015 to 2016
4 MARKET SEGMENTS AND FORECAST OF DRUGS FOR TREATMENT OF PROSTATE CANCER BY REGIONS
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
5 RAW MATERIALS AND APPLICATIONS
5.1 Key Raw Materials and Price Analysis for Triptorelin
5.1.1 Key Raw Materials for Triptorelin
5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Leuprorelin
5.2.1 Key Raw Materials for Leuprorelin
5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Flutamide Tablets
5.3.1 Key Raw Materials for Flutamide Tablets
5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Goserelin
5.4.1 Key Raw Materials for Goserelin
5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets
5.5.1 Key Raw Materials for Bicalutamide Tablets
5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules
5.6.1 Key Raw Materials for Bicalutamide Capsules
5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules
5.7.1 Key Raw Materials for Estramustine Phosphate Capsules
5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Mitoxantrone
5.8.1 Key Raw Materials for Mitoxantrone
5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Zytiga
5.9.1 Key Raw Materials for Zytiga
5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Xtandi
5.10.1 Key Raw Materials for Xtandi
5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021
5.11 Applications of Triptorelin
5.12 Applications of Leuprorelin
5.13 Applications of Flutamide Tablets
5.14 Applications of Goserelin
5.15 Applications of Bicalutamide Tablets
5.16 Applications of Bicalutamide Capsules
5.17 Applications of Estramustine Phosphate Capsules
5.18 Applications of Mitoxantrone
5.19 Applications of Zytiga
5.20 Applications of Xtandi
6 KEY MANUFACTURERS ANALYSIS OF DRUGS FOR TREATMENT OF PROSTATE CANCER
6.1 IPSEN
6.1.1 IPSEN Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.1.4 Interviewee, Name and Contact
6.2 Ferring Pharmaceuticals
6.2.1 Company Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.4 Interviewee, Name and Contact
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Company Basic Information
6.3.2 Triptorelin (Specification and Price)
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.4 Interviewee, Name and Contact
6.4 GeneScience Pharmaceuticals
6.4.1 Company Basic Information
6.4.2 Triptorelin (Specification and Price)
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.4 Interviewee, Name and Contact
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Basic Information
6.5.2 Leuprorelin (Specification and Price)
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.4 Interviewee, Name and Contact
6.6 Beijing Biote Pharmaceutical
6.6.1 Company Basic Information
6.6.2 Leuprorelin (Specification and Price)
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.4 Interviewee, Name and Contact
6.7 Livzon Pharmaceutical Group
6.7.1 Company Basic Information
6.7.2 Leuprorelin (Specification and Price)
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.4 Interviewee, Name and Contact
6.8 Schering-Plough Canada
6.8.1 Company Basic Information
6.8.2 Flutamide Tablets (Specification and Price)
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.4 Interviewee, Name and Contact
6. 9 JIANGSU TASLY DI YI PHARMACEUTICAL
6.9.1 Company Basic Information
6.9.2 Flutamide Tablets (Specification and Price)
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.4 Interviewee, Name and Contact
6.10 Shanghai Fudan Fuhua Pharmaceutical
6.10.1 Company Basic Information
6.10.2 Flutamide Tablets (Specification and Price)
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.4 Interviewee, Name and Contact
6.11 S.C.SINDAN-PHARMA S.R.L.
6.11.1 Company Basic Information
6.11.2 Flutamide Tablets (Specification and Price)
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.4 Interviewee, Name and Contact
6.12 AstraZeneca
6.12.1 Company Basic Information
6.12.2 Goserelin (Specification and Price)
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.4 Interviewee, Name and Contact
6.13 Corden Pharma GmbH
6.13.1 Company Basic Information
6.13.2 Bicalutamide Tablets (Specification and Price)
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.4 Interviewee, Name and Contact
6.14 Shanghai Zhaohui Pharmaceutical
6.14.1 Company Basic Information
6.14.2 Bicalutamide Tablets (Specification and Price)
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.4 Interviewee, Name and Contact
6.15 HISUN Pharmaceutical
6.15.1 Company Basic Information
6.15.2 Bicalutamide Tablets (Specification and Price)
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.4 Interviewee, Name and Contact
6.16 Shanxi Zhendong Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Bicalutamide Capsules (Specification and Price)
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.4 Interviewee, Name and Contact
6.17 Pfizer
6.17.1 Company Basic Information
6.17.2 Estramustine Phosphate Capsules (Specification and Price)
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.4 Interviewee, Name and Contact
6.18 Sichuan sunnyhope pharmaceutical
6.18.1 Company Basic Information
6.18.2 Mitoxantrone (Specification and Price)
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.4 Interviewee, Name and Contact
6.19 Luoxin Group
6.19.1 Company Basic Information
6.19.2 Mitoxantrone (Specification and Price)
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.4 Interviewee, Name and Contact
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Company Basic Information
6.20.2 Mitoxantrone (Specification and Price)
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.4 Interviewee, Name and Contact
6.21 JIANG SU HENG RUI MEDICINE
6.21.1 Company Basic Information
6.21.2 Mitoxantrone (Specification and Price)
6.21.3 Sales Value, Gross Margin 2011-2016
6.21.4 Interviewee, Name and Contact
6.22 Johnson
6.22.1 Company Basic Information
6.22.2 Zytiga (Specification and Price)
6.22.3 Sales Value, Gross Margin 2011-2016
6.22.4 Interviewee, Name and Contact
6.23 Astellas
6.23.1 Company Basic Information
6.23.2 Xtandi (Specification and Price)
6.23.3 Sales Value, Gross Margin 2011-2016
6.23.4 Interviewee, Name and Contact
7 TECHNOLOGY DEVELOPMENT TREND
7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 RESEARCH FINDINGS AND CONCLUSION
1 DRUGS FOR TREATMENT OF PROSTATE CANCER OVERVIEW AND EACH TYPE
1.1 Product Overview of Prostate Cancer
1.1.1 Definition and Product Scope of Drugs for Prostate Cancer
1.1.2 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.3 Russia Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.4 Brazil Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.1.5 Japan Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021
1.2 Product Segments and Price of Each Type
1.2.1 Product Type of Key Manufacturers
1.2.2 Price List and of Each Type 2015 to 2016
1.2.3 Market Share and Growth Rate of Each Type
1.2.4 Triptorelin and Specification
1.2.5 Leuprorelin and Specification
1.2.6 Flutamide Tablets and Specification
1.2.7 Goserelin and Specification
1.2.8 Bicalutamide Tablets and Specification
1.2.9 Bicalutamide Capsules and Specification
1.2.10 Estramustine Phosphate Capsules and Specification
1.2.11 Mitoxantrone and Specification
1.2.12 Zytiga and Specification
1.2.13 Xtandi and Specification
1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016
1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers
1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers
1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers
1.3.4 Price List (Interviewed) of Goserelin by Manufacturers
1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers
1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers
1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers
1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers
1.3.9 Price List (Interviewed) of Zytiga by Manufacturers
1.3.10 Price List (Interviewed) of Xtandi by Manufacturers
2 COMPETITION ANALYSIS BY MANUFACTURERS IN GLOBAL AND CHINA
2.1 Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016
2.2 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.3 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.4 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.5 Russia Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.6 Russia Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.7 Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.8 Brazil Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.9 Brazil Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.10 Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
2.11 Japan Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015
2.12 Japan Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015
2.13 Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016
3 SALES AND REVENUE SEGMENTS OF EACH TYPE 2010 TO 2015
3.1 China Sales and Revenue Segments of Each Type 2010 to 2015
3.1.1 China Sales and Market Share of Each Type 2010 to 2015
3.1.2 China Sales Growth Rate of Each Type 2015 to 2016
3.1.3 China Revenue and Market Share of Each Type 2015 to 2016
3.1.4 China Revenue and Market Share of Each Type 2015 to 2016
3.2 Russia Sales and Revenue Segments of Each Type 2015 to 2016
3.2.1 Russia Sales and Market Share of Each Type 2015 to 2016
3.2.2 Russia Sales Growth Rate of Each Type 2015 to 2016
3.2.3 Russia Revenue and Market Share of Each Type 2015 to 2016
3.2.4 Russia Revenue and Market Share of Each Type 2015 to 2016
3.3 Brazil Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Brazil Sales and Market Share of Each Type 2015 to 2016
3.3.2 Brazil Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Brazil Revenue and Market Share of Each Type 2015 to 2016
3.4 Japan Sales and Revenue Segments of Each Type 2015 to 2016
3.3.1 Japan Sales and Market Share of Each Type 2015 to 2016
3.3.2 Japan Sales Growth Rate of Each Type 2015 to 2016
3.3.3 Japan Revenue and Market Share of Each Type 2015 to 2016
3.3.4 Japan Revenue and Market Share of Each Type 2015 to 2016
4 MARKET SEGMENTS AND FORECAST OF DRUGS FOR TREATMENT OF PROSTATE CANCER BY REGIONS
4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021
4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021
5 RAW MATERIALS AND APPLICATIONS
5.1 Key Raw Materials and Price Analysis for Triptorelin
5.1.1 Key Raw Materials for Triptorelin
5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021
5.2 Key Raw Materials and Price Analysis for Leuprorelin
5.2.1 Key Raw Materials for Leuprorelin
5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021
5.3 Key Raw Materials and Price Analysis for Flutamide Tablets
5.3.1 Key Raw Materials for Flutamide Tablets
5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021
5.4 Key Raw Materials and Price Analysis for Goserelin
5.4.1 Key Raw Materials for Goserelin
5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021
5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets
5.5.1 Key Raw Materials for Bicalutamide Tablets
5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021
5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules
5.6.1 Key Raw Materials for Bicalutamide Capsules
5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021
5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules
5.7.1 Key Raw Materials for Estramustine Phosphate Capsules
5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021
5.8 Key Raw Materials and Price Analysis for Mitoxantrone
5.8.1 Key Raw Materials for Mitoxantrone
5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021
5.9 Key Raw Materials and Price Analysis for Zytiga
5.9.1 Key Raw Materials for Zytiga
5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021
5.10 Key Raw Materials and Price Analysis for Xtandi
5.10.1 Key Raw Materials for Xtandi
5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021
5.11 Applications of Triptorelin
5.12 Applications of Leuprorelin
5.13 Applications of Flutamide Tablets
5.14 Applications of Goserelin
5.15 Applications of Bicalutamide Tablets
5.16 Applications of Bicalutamide Capsules
5.17 Applications of Estramustine Phosphate Capsules
5.18 Applications of Mitoxantrone
5.19 Applications of Zytiga
5.20 Applications of Xtandi
6 KEY MANUFACTURERS ANALYSIS OF DRUGS FOR TREATMENT OF PROSTATE CANCER
6.1 IPSEN
6.1.1 IPSEN Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.1.4 Interviewee, Name and Contact
6.2 Ferring Pharmaceuticals
6.2.1 Company Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.4 Interviewee, Name and Contact
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Company Basic Information
6.3.2 Triptorelin (Specification and Price)
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.4 Interviewee, Name and Contact
6.4 GeneScience Pharmaceuticals
6.4.1 Company Basic Information
6.4.2 Triptorelin (Specification and Price)
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.4 Interviewee, Name and Contact
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Basic Information
6.5.2 Leuprorelin (Specification and Price)
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.4 Interviewee, Name and Contact
6.6 Beijing Biote Pharmaceutical
6.6.1 Company Basic Information
6.6.2 Leuprorelin (Specification and Price)
6.6.3 Sales Value, Gross Margin 2011-2016
6.6.4 Interviewee, Name and Contact
6.7 Livzon Pharmaceutical Group
6.7.1 Company Basic Information
6.7.2 Leuprorelin (Specification and Price)
6.7.3 Sales Value, Gross Margin 2011-2016
6.7.4 Interviewee, Name and Contact
6.8 Schering-Plough Canada
6.8.1 Company Basic Information
6.8.2 Flutamide Tablets (Specification and Price)
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.3 Sales Value, Gross Margin 2011-2016
6.8.4 Interviewee, Name and Contact
6. 9 JIANGSU TASLY DI YI PHARMACEUTICAL
6.9.1 Company Basic Information
6.9.2 Flutamide Tablets (Specification and Price)
6.9.3 Sales Value, Gross Margin 2011-2016
6.9.4 Interviewee, Name and Contact
6.10 Shanghai Fudan Fuhua Pharmaceutical
6.10.1 Company Basic Information
6.10.2 Flutamide Tablets (Specification and Price)
6.10.3 Sales Value, Gross Margin 2011-2016
6.10.4 Interviewee, Name and Contact
6.11 S.C.SINDAN-PHARMA S.R.L.
6.11.1 Company Basic Information
6.11.2 Flutamide Tablets (Specification and Price)
6.11.3 Sales Value, Gross Margin 2011-2016
6.11.4 Interviewee, Name and Contact
6.12 AstraZeneca
6.12.1 Company Basic Information
6.12.2 Goserelin (Specification and Price)
6.12.3 Sales Value, Gross Margin 2011-2016
6.12.4 Interviewee, Name and Contact
6.13 Corden Pharma GmbH
6.13.1 Company Basic Information
6.13.2 Bicalutamide Tablets (Specification and Price)
6.13.3 Sales Value, Gross Margin 2011-2016
6.13.4 Interviewee, Name and Contact
6.14 Shanghai Zhaohui Pharmaceutical
6.14.1 Company Basic Information
6.14.2 Bicalutamide Tablets (Specification and Price)
6.14.3 Sales Value, Gross Margin 2011-2016
6.14.4 Interviewee, Name and Contact
6.15 HISUN Pharmaceutical
6.15.1 Company Basic Information
6.15.2 Bicalutamide Tablets (Specification and Price)
6.15.3 Sales Value, Gross Margin 2011-2016
6.15.4 Interviewee, Name and Contact
6.16 Shanxi Zhendong Pharmaceutical
6.16.1 Company Basic Information
6.16.2 Bicalutamide Capsules (Specification and Price)
6.16.3 Sales Value, Gross Margin 2011-2016
6.16.4 Interviewee, Name and Contact
6.17 Pfizer
6.17.1 Company Basic Information
6.17.2 Estramustine Phosphate Capsules (Specification and Price)
6.17.3 Sales Value, Gross Margin 2011-2016
6.17.4 Interviewee, Name and Contact
6.18 Sichuan sunnyhope pharmaceutical
6.18.1 Company Basic Information
6.18.2 Mitoxantrone (Specification and Price)
6.18.3 Sales Value, Gross Margin 2011-2016
6.18.4 Interviewee, Name and Contact
6.19 Luoxin Group
6.19.1 Company Basic Information
6.19.2 Mitoxantrone (Specification and Price)
6.19.3 Sales Value, Gross Margin 2011-2016
6.19.4 Interviewee, Name and Contact
6.20 Jiangsu Aosaikang Pharmaceutical
6.20.1 Company Basic Information
6.20.2 Mitoxantrone (Specification and Price)
6.20.3 Sales Value, Gross Margin 2011-2016
6.20.4 Interviewee, Name and Contact
6.21 JIANG SU HENG RUI MEDICINE
6.21.1 Company Basic Information
6.21.2 Mitoxantrone (Specification and Price)
6.21.3 Sales Value, Gross Margin 2011-2016
6.21.4 Interviewee, Name and Contact
6.22 Johnson
6.22.1 Company Basic Information
6.22.2 Zytiga (Specification and Price)
6.22.3 Sales Value, Gross Margin 2011-2016
6.22.4 Interviewee, Name and Contact
6.23 Astellas
6.23.1 Company Basic Information
6.23.2 Xtandi (Specification and Price)
6.23.3 Sales Value, Gross Margin 2011-2016
6.23.4 Interviewee, Name and Contact
7 TECHNOLOGY DEVELOPMENT TREND
7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer
7.2 Analysis of Manufacturing Process
7.3 Development Trend
8 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Drugs for Prostate Cancer 17
Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17
Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 17
Figure Russia Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17
Figure Russia Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18
Figure Brazil Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18
Figure Brazil Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18
Figure Japan Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18
Figure Japan Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18
Table Product Type of Key Manufacturers 18
Table Price List and Forecast of Each Type 19
Table Market Share of Each Type 19
Figure Growth Rate of Each Type 2014 to 2015 20
Figure Picture of Triptorelin 20
Table Specification of Triptorelin 20
Figure Picture of Leuprorelin 20
Table Specification of Leuprorelin 20
Figure Picture of Flutamide Tablets 21
Table Specification of Flutamide Tablets 21
Figure Picture of Goserelin 21
Table Specification of Goserelin 21
Figure Picture of Bicalutamide Tablets 21
Table Specification of Bicalutamide Tablets 21
Figure Picture of Type Bicalutamide Capsules 21
Table Specification of Type Bicalutamide Capsules 21
Figure Picture of Estramustine Phosphate Capsules 22
Table Specification of Estramustine Phosphate Capsules 22
Figure Picture of Mitoxantrone 22
Table Specification of Mitoxantrone 22
Figure Picture of Zytiga 22
Table Specification of Zytiga 22
Figure Picture of Xtandi 22
Table Specification of Xtandi 23
Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016 23
Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016 23
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24
Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016 25
Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016 25
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26
Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016 27
Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016 27
Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016 28
Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016 28
Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 29
Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 29
Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 30
Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 30
Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 31
Table Russia Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 32
Table Russia Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 32
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 33
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 33
Table Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 34
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 34
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 35
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 35
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 36
Table Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 36
Table Japan Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 37
Table Japan Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 37
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 38
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 39
Table Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 39
Table China Sales of Each Type 2010 to 2015 40
Table China Sales Market Share of Each Type 2010 to 2015 40
Table China Sales Growth Rate of Each Type 2015 to 2016 40
Table China Revenue of Each Type 2015 to 2016 41
Table China Revenue Market Share of Each Type 2015 to 2016 41
Table China Revenue of Each Type 2015 to 2016 41
Table China Revenue Market Share of Each Type 2015 to 2016 42
Table Global Sales of Each Type 2015 to 2016 42
Table Russia Sales Market Share of Each Type 2015 to 2016 42
Table Global Sales Growth Rate of Each Type 2015 to 2016 42
Table Global Revenue of Each Type 2015 to 2016 43
Table Russia Revenue Market Share of Each Type 2015 to 2016 43
Table Russia Revenue of Each Type 2015 to 2016 43
Table Russia Revenue Market Share of Each Type 2015 to 2016 44
Table Brazil Sales of Each Type 2015 to 2016 44
Table Brazil Sales Market Share of Each Type 2015 to 2016 44
Table Brazil Sales Growth Rate of Each Type 2015 to 2016 45
Table Brazil Revenue of Each Type 2015 to 2016 45
Table Brazil Revenue Market Share of Each Type 2015 to 2016 45
Table Brazil Revenue of Each Type 2015 to 2016 45
Table Brazil Revenue Market Share of Each Type 2015 to 2016 46
Table Japan Sales of Each Type 2015 to 2016 46
Table Japan Sales Market Share of Each Type 2015 to 2016 46
Table Japan Sales Growth Rate of Each Type 2015 to 2016 47
Table Japan Revenue of Each Type 2015 to 2016 47
Table Japan Revenue Market Share of Each Type 2015 to 2016 47
Table Japan Revenue of Each Type 2015 to 2016 47
Table Japan Revenue Market Share of Each Type 2015 to 2016 48
Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 49
Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 50
Table Key Raw Materials for Triptorelin 51
Table Price Forecast of Key Raw Materials for Triptorelin 51
Table Key Raw Materials for Leuprorelin 52
Table Price Forecast of Key Raw Materials for Leuprorelin 52
Table Key Raw Materials for Flutamide Tablets 52
Table Price Forecast of Key Raw Materials for Flutamide Tablets 53
Table Key Raw Materials for Goserelin 53
Table Price Forecast of Key Raw Materials for Goserelin 53
Table Key Raw Materials for Bicalutamide Tablets 54
Table Price Forecast of Key Raw Materials for Bicalutamide Tablets 54
Table Key Raw Materials for Bicalutamide Capsules 55
Table Price Forecast of Key Raw Materials for Bicalutamide Capsules 55
Table Key Raw Materials for Estramustine Phosphate Capsules 55
Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 56
Table Key Raw Materials for Mitoxantrone 56
Table Price Forecast of Key Raw Materials for Mitoxantrone 57
Table Key Raw Materials for Zytiga 57
Table Price Forecast of Key Raw Materials for Zytiga 57
Table Key Raw Materials for Xtandi 58
Table Price Forecast of Key Raw Materials for Zytiga 58
Table Applications of Triptorelin 58
Table Applications of Leuprorelin 59
Table Applications of Flutamide Tablets 59
Table Applications of Goserelin 59
Table Applications of Bicalutamide Tablets 59
Table Applications of Bicalutamide Capsules 60
Table Applications of Estramustine Phosphate Capsules 60
Table Applications of Mitoxantrone 60
Table Applications of Zytiga 61
Table Applications of Xtandi 61
Table IPSEN Basic Information List 62
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of IPSEN 62
Table Sales Value, Gross Margin and Growth rate of IPSEN in China 62
Figure Product Sales Value, Growth rate of IPSEN in China 63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Russia 63
Figure Product Sales Value, Growth rate of IPSEN in Russia 63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Brazil 63
Figure Product Sales Value, Growth rate of IPSEN in Brazil 63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Japan 63
Figure Product Sales Value, Growth rate of IPSEN in Japan 64
Table Ferring Pharmaceuticals Basic Information List 64
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Ferring Pharmaceuticals 64
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in China 65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in China 65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Russia 65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Russia 65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Brazil 65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Brazil 65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Japan 66
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Japan 66
Table Chengdu Tiantaishan pharmaceutical Basic Information List 66
Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical in China 67
Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical in China 67
Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical in China 67
Table GeneScience Pharmaceuticals Basic Information List 67
Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals in China 68
Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals in China 68
Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals in China 68
Table Takeda Pharmaceutical Company Limited Basic Information List 69
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Takeda Pharmaceutical Company Limited 69
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in China 69
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in China 70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Russia 70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Russia 70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Japan 70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Japan 71
Table Beijing Biote Pharmaceutical Basic Information List 71
Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical in China 71
Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical in China 72
Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical in China 72
Table Livzon Pharmaceutical Group Basic Information List 72
Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group in China 73
Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group in China 73
Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group in China 73
Table Schering-Plough Canada Basic Information List 73
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Schering-Plough Canada 74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in China 74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in China 74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Russia 74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Russia 75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Brazil 75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Brazil 75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Japan 75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Japan 75
Table JiangSu TASLY DI YI Pharmaceutical Basic Information List 76
Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical in China 76
Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 76
Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 77
Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List 77
Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical in China 77
Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78
Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78
Table S.C.SINDAN-PHARMA S.R.L. Basic Information List 78
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of S.C.SINDAN-PHARMA S.R.L. 79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80
Table AstraZeneca Basic Information List 80
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in China 81
Figure Product Sales Value, Growth rate of AstraZeneca in China 81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Russia 81
Figure Product Sales Value, Growth rate of AstraZeneca in Russia 82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Brazil 82
Figure Product Sales Value, Growth rate of AstraZeneca in Brazil 82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Japan 82
Figure Product Sales Value, Growth rate of AstraZeneca in Japan 82
Table Corden Pharma GmbH Basic Information List 83
Table Specification, Price, Sales Value(China, Russia, Brazil and Japan)and Market Share of Corden Pharma GmbH 83
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in China 83
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in China 84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Russia 84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Russia 84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Brazil 84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Brazil 84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Japan 84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Japan 85
Table Shanghai Zhaohui Pharmaceutical Basic Information List 85
Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical in China 85
Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical in China 86
Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical in China 86
Table HISUN Pharmaceutical Basic Information List 86
Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical in China 87
Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical in China 87
Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical in China 87
Table Shanxi Zhendong Pharmaceutical Basic Information List 87
Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical in China 88
Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical in China 88
Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical in China 88
Table Pfizer Basic Information List 89
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 89
Table Sales Value, Gross Margin and Growth rate of Pfizer in China 89
Figure Product Sales Value, Growth rate of Pfizer in China 90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Russia 90
Figure Product Sales Value, Growth rate of Pfizer in Russia 90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Brazil 90
Figure Product Sales Value, Growth rate of Pfizer in Brazil 90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Japan 90
Figure Product Sales Value, Growth rate of Pfizer in Japan 90
Table Sichuan sunnyhope pharmaceutical Basic Information List 91
Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical in China 91
Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical in China 91
Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical in China 92
Table Luoxin Group Basic Information List 92
Table Specification, Price, Sales Value and Market Share of Luoxin Group in China 92
Table Sales Value, Gross Margin and Growth rate of Luoxin Group in China 93
Figure Product Sales Value, Growth rate of Luoxin Group in China 93
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 93
Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical in China 94
Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical in China 94
Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical 94
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 94
Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE in China 95
Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE China 95
Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE in China 95
Table Johnson Basic Information List 96
Table Specification, Price, Sales Value and Market Share of Johnson in Japan 96
Table Sales Value, Gross Margin and Growth rate of Johnson in Japan 96
Figure Product Sales Value, Growth rate of Johnson in Japan 96
Table Sales Value, Gross Margin and Growth rate of Johnson in Russia 97
Figure Product Sales Value, Growth rate of Johnson in Russia 97
Table Astellas Basic Information List 97
Table Specification, Price, Sales Value and Market Share of Astellas in Japan 97
Table Sales Value, Gross Margin and Growth rate of Astellas in Japan 98
Figure Product Sales Value, Growth rate of Astellas in Japan 98
Figure Picture of Drugs for Prostate Cancer 17
Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17
Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 17
Figure Russia Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17
Figure Russia Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18
Figure Brazil Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18
Figure Brazil Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18
Figure Japan Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18
Figure Japan Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18
Table Product Type of Key Manufacturers 18
Table Price List and Forecast of Each Type 19
Table Market Share of Each Type 19
Figure Growth Rate of Each Type 2014 to 2015 20
Figure Picture of Triptorelin 20
Table Specification of Triptorelin 20
Figure Picture of Leuprorelin 20
Table Specification of Leuprorelin 20
Figure Picture of Flutamide Tablets 21
Table Specification of Flutamide Tablets 21
Figure Picture of Goserelin 21
Table Specification of Goserelin 21
Figure Picture of Bicalutamide Tablets 21
Table Specification of Bicalutamide Tablets 21
Figure Picture of Type Bicalutamide Capsules 21
Table Specification of Type Bicalutamide Capsules 21
Figure Picture of Estramustine Phosphate Capsules 22
Table Specification of Estramustine Phosphate Capsules 22
Figure Picture of Mitoxantrone 22
Table Specification of Mitoxantrone 22
Figure Picture of Zytiga 22
Table Specification of Zytiga 22
Figure Picture of Xtandi 22
Table Specification of Xtandi 23
Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016 23
Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016 23
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24
Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24
Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016 25
Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016 25
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26
Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26
Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016 27
Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016 27
Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016 28
Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016 28
Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 29
Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 29
Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 30
Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 30
Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 31
Table Russia Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 32
Table Russia Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 32
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 33
Table Russia Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 33
Table Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 34
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 34
Table Brazil Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 35
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 35
Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 36
Table Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 36
Table Japan Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 37
Table Japan Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 37
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 38
Table Japan Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 39
Table Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 39
Table China Sales of Each Type 2010 to 2015 40
Table China Sales Market Share of Each Type 2010 to 2015 40
Table China Sales Growth Rate of Each Type 2015 to 2016 40
Table China Revenue of Each Type 2015 to 2016 41
Table China Revenue Market Share of Each Type 2015 to 2016 41
Table China Revenue of Each Type 2015 to 2016 41
Table China Revenue Market Share of Each Type 2015 to 2016 42
Table Global Sales of Each Type 2015 to 2016 42
Table Russia Sales Market Share of Each Type 2015 to 2016 42
Table Global Sales Growth Rate of Each Type 2015 to 2016 42
Table Global Revenue of Each Type 2015 to 2016 43
Table Russia Revenue Market Share of Each Type 2015 to 2016 43
Table Russia Revenue of Each Type 2015 to 2016 43
Table Russia Revenue Market Share of Each Type 2015 to 2016 44
Table Brazil Sales of Each Type 2015 to 2016 44
Table Brazil Sales Market Share of Each Type 2015 to 2016 44
Table Brazil Sales Growth Rate of Each Type 2015 to 2016 45
Table Brazil Revenue of Each Type 2015 to 2016 45
Table Brazil Revenue Market Share of Each Type 2015 to 2016 45
Table Brazil Revenue of Each Type 2015 to 2016 45
Table Brazil Revenue Market Share of Each Type 2015 to 2016 46
Table Japan Sales of Each Type 2015 to 2016 46
Table Japan Sales Market Share of Each Type 2015 to 2016 46
Table Japan Sales Growth Rate of Each Type 2015 to 2016 47
Table Japan Revenue of Each Type 2015 to 2016 47
Table Japan Revenue Market Share of Each Type 2015 to 2016 47
Table Japan Revenue of Each Type 2015 to 2016 47
Table Japan Revenue Market Share of Each Type 2015 to 2016 48
Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 49
Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 50
Table Key Raw Materials for Triptorelin 51
Table Price Forecast of Key Raw Materials for Triptorelin 51
Table Key Raw Materials for Leuprorelin 52
Table Price Forecast of Key Raw Materials for Leuprorelin 52
Table Key Raw Materials for Flutamide Tablets 52
Table Price Forecast of Key Raw Materials for Flutamide Tablets 53
Table Key Raw Materials for Goserelin 53
Table Price Forecast of Key Raw Materials for Goserelin 53
Table Key Raw Materials for Bicalutamide Tablets 54
Table Price Forecast of Key Raw Materials for Bicalutamide Tablets 54
Table Key Raw Materials for Bicalutamide Capsules 55
Table Price Forecast of Key Raw Materials for Bicalutamide Capsules 55
Table Key Raw Materials for Estramustine Phosphate Capsules 55
Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 56
Table Key Raw Materials for Mitoxantrone 56
Table Price Forecast of Key Raw Materials for Mitoxantrone 57
Table Key Raw Materials for Zytiga 57
Table Price Forecast of Key Raw Materials for Zytiga 57
Table Key Raw Materials for Xtandi 58
Table Price Forecast of Key Raw Materials for Zytiga 58
Table Applications of Triptorelin 58
Table Applications of Leuprorelin 59
Table Applications of Flutamide Tablets 59
Table Applications of Goserelin 59
Table Applications of Bicalutamide Tablets 59
Table Applications of Bicalutamide Capsules 60
Table Applications of Estramustine Phosphate Capsules 60
Table Applications of Mitoxantrone 60
Table Applications of Zytiga 61
Table Applications of Xtandi 61
Table IPSEN Basic Information List 62
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of IPSEN 62
Table Sales Value, Gross Margin and Growth rate of IPSEN in China 62
Figure Product Sales Value, Growth rate of IPSEN in China 63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Russia 63
Figure Product Sales Value, Growth rate of IPSEN in Russia 63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Brazil 63
Figure Product Sales Value, Growth rate of IPSEN in Brazil 63
Table Sales Value, Gross Margin and Growth rate of IPSEN in Japan 63
Figure Product Sales Value, Growth rate of IPSEN in Japan 64
Table Ferring Pharmaceuticals Basic Information List 64
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Ferring Pharmaceuticals 64
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in China 65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in China 65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Russia 65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Russia 65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Brazil 65
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Brazil 65
Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Japan 66
Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Japan 66
Table Chengdu Tiantaishan pharmaceutical Basic Information List 66
Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical in China 67
Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical in China 67
Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical in China 67
Table GeneScience Pharmaceuticals Basic Information List 67
Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals in China 68
Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals in China 68
Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals in China 68
Table Takeda Pharmaceutical Company Limited Basic Information List 69
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Takeda Pharmaceutical Company Limited 69
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in China 69
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in China 70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Russia 70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Russia 70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70
Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Japan 70
Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Japan 71
Table Beijing Biote Pharmaceutical Basic Information List 71
Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical in China 71
Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical in China 72
Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical in China 72
Table Livzon Pharmaceutical Group Basic Information List 72
Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group in China 73
Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group in China 73
Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group in China 73
Table Schering-Plough Canada Basic Information List 73
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Schering-Plough Canada 74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in China 74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in China 74
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Russia 74
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Russia 75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Brazil 75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Brazil 75
Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Japan 75
Figure Product Sales Value, Growth rate of Schering-Plough Canada in Japan 75
Table JiangSu TASLY DI YI Pharmaceutical Basic Information List 76
Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical in China 76
Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 76
Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 77
Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List 77
Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical in China 77
Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78
Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78
Table S.C.SINDAN-PHARMA S.R.L. Basic Information List 78
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of S.C.SINDAN-PHARMA S.R.L. 79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80
Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80
Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80
Table AstraZeneca Basic Information List 80
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in China 81
Figure Product Sales Value, Growth rate of AstraZeneca in China 81
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Russia 81
Figure Product Sales Value, Growth rate of AstraZeneca in Russia 82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Brazil 82
Figure Product Sales Value, Growth rate of AstraZeneca in Brazil 82
Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Japan 82
Figure Product Sales Value, Growth rate of AstraZeneca in Japan 82
Table Corden Pharma GmbH Basic Information List 83
Table Specification, Price, Sales Value(China, Russia, Brazil and Japan)and Market Share of Corden Pharma GmbH 83
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in China 83
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in China 84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Russia 84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Russia 84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Brazil 84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Brazil 84
Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Japan 84
Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Japan 85
Table Shanghai Zhaohui Pharmaceutical Basic Information List 85
Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical in China 85
Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical in China 86
Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical in China 86
Table HISUN Pharmaceutical Basic Information List 86
Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical in China 87
Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical in China 87
Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical in China 87
Table Shanxi Zhendong Pharmaceutical Basic Information List 87
Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical in China 88
Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical in China 88
Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical in China 88
Table Pfizer Basic Information List 89
Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 89
Table Sales Value, Gross Margin and Growth rate of Pfizer in China 89
Figure Product Sales Value, Growth rate of Pfizer in China 90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Russia 90
Figure Product Sales Value, Growth rate of Pfizer in Russia 90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Brazil 90
Figure Product Sales Value, Growth rate of Pfizer in Brazil 90
Table Sales Value, Gross Margin and Growth rate of Pfizer in Japan 90
Figure Product Sales Value, Growth rate of Pfizer in Japan 90
Table Sichuan sunnyhope pharmaceutical Basic Information List 91
Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical in China 91
Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical in China 91
Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical in China 92
Table Luoxin Group Basic Information List 92
Table Specification, Price, Sales Value and Market Share of Luoxin Group in China 92
Table Sales Value, Gross Margin and Growth rate of Luoxin Group in China 93
Figure Product Sales Value, Growth rate of Luoxin Group in China 93
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 93
Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical in China 94
Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical in China 94
Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical 94
Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 94
Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE in China 95
Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE China 95
Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE in China 95
Table Johnson Basic Information List 96
Table Specification, Price, Sales Value and Market Share of Johnson in Japan 96
Table Sales Value, Gross Margin and Growth rate of Johnson in Japan 96
Figure Product Sales Value, Growth rate of Johnson in Japan 96
Table Sales Value, Gross Margin and Growth rate of Johnson in Russia 97
Figure Product Sales Value, Growth rate of Johnson in Russia 97
Table Astellas Basic Information List 97
Table Specification, Price, Sales Value and Market Share of Astellas in Japan 97
Table Sales Value, Gross Margin and Growth rate of Astellas in Japan 98
Figure Product Sales Value, Growth rate of Astellas in Japan 98
